CompletedNot applicableNCT04629274

In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

Studying Neuromyelitis Optica

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Imcyse SA
Principal Investigator
Jerome De Seze, MD
Hôpital de Hautepierre, Strasbourg
Intervention
Blood sampling(procedure)
Enrollment
15 enrolled
Eligibility
18-65 years · All sexes
Timeline
2020 – 2024

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04629274 on ClinicalTrials.gov

Other trials for Neuromyelitis Optica

Additional recruiting or active studies for the same condition.

See all trials for Neuromyelitis Optica →

← Back to all trials